MedPath

Retrospective Evaluation of Cellulite of Laxity Treatment Using Body Tite

Completed
Conditions
Cellulite
Registration Number
NCT04419454
Lead Sponsor
InMode MD Ltd.
Brief Summary

Retrospective Evaluation of Cellulite of Laxity Treatment Using Body Tite

Detailed Description

The purpose of this preliminary report is to retrospectively evaluate this novel treatment approach to improve the appearance of cellulite on the thighs and buttocks by tightening the SFS using RFAL.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
10
Inclusion Criteria
  • age ≥ 18years of age at the time of procedure

    • patients with localized lipodystrophy in the medial or lateral thigh, and visible cellulite of laxity in the lower extremity or buttocks
    • BodyTite treatments performed from January 2018 - May 2019 for Cellulite indication
Exclusion Criteria
  • active infection, collagen disorders, immunocompromised state, medications that mitigate inflammatory response, and propensity for keloid/hypertrophic scaring. o BodyTite treatments performed from March 2018 - May 2019 for lipodystrophy and cellulite of laxity

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Photonumeric Cellulite Severity Score[ Time Frame: Baseline to 6 months posttreatment]

Change in Photonumeric Cellulite Severity Score 3. Investigator assessment of the cellulite improvement comparing pre and post treatment using Global aesthetic improvement 5-point grading scale (0=No change, 1=1%-24%%, 2=25%-49%, 3=50%-74% improvement, and 4=75%-100%) at all follow up visits.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dr. Mark Peters

🇺🇸

Germantown, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath